Nuwellis (NASDAQ:NUWE) Shares Up 2.4% – Still a Buy?

Shares of Nuwellis, Inc. (NASDAQ:NUWE) shot up 2.4% on Wednesday . The stock traded as high as $1.11 and last traded at $1.09. 76,039 shares changed hands during trading, a decline of 92% from the average session volume of 898,355 shares. The stock had previously closed at $1.06.

Nuwellis Price Performance

The stock’s 50-day moving average price is $1.50 and its 200-day moving average price is $2.45. The company has a market cap of $4.75 million, a P/E ratio of -0.01 and a beta of 0.32.

Nuwellis (NASDAQ:NUWE) last announced its quarterly earnings data on Monday, November 11th. The company reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.88) by $2.62. The firm had revenue of $2.37 million for the quarter, compared to the consensus estimate of $2.40 million. Nuwellis had a negative net margin of 169.54% and a negative return on equity of 28,159.25%. During the same period in the prior year, the company posted ($63.29) earnings per share. As a group, analysts expect that Nuwellis, Inc. will post -9.91 EPS for the current fiscal year.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.